SUNNYVALE, CA–Apr 21, 2009 — Arrayit Corporation (OTC BB:ARYC.OB – News), a life sciences and healthcare technology leader, announces a scientific breakthrough that accelerates the analysis of the human genome. The scientific discovery by Arrayit scientists, which combines advances in surface chemistry, bioinformatics, instrumentation and microarray technology, reduces the time required to analyze the human […]

Key placements prove growing market need for inkjet microarrayer platform April 17th 2009, Roslin UK: Arrayjet today announced that it had successfully installed a further four instruments in key microarray labs across North America during the past 12 months. The instruments in question, all Marathon or Super-Marathon Inkjet Microarrayers, were installed in prestigious laboratories: UHN […]

Paul Keim brings deep knowledge in the field of medical microbiology, biodefense and pathogens to febit, the leader in microfluidic microarray DNA analysis technologies LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, April 14, 2009 – febit today announced the recruitment of Paul Keim, Ph.D., for its Scientific Advisory Board. Dr. Keim is Senior Investigator and Director […]

AACR Annual Meeting CHICAGO–Precision Biomarker Resources, a contract research organization based in Evanston, Illinois, is the first Service Provider to offer microRNA Profiling using the new GeneChip® miRNA Arrays recently released by Affymetrix, Inc. Precision Biomarker provides RNA and microRNA (miRNA) profiling and data analysis services for pharmaceutical, biotechnology and academic researchers who use microarray […]

LARKSPUR, Calif., April 9 — Jivan announced today that it will provide bioinformatics solutions for high-throughput transcriptome sequencing (RNA-Seq) and expression. Leveraging Jivan’s industry-leading bioinformatics infrastructure for analysis of mRNA in biological samples, Jivan will provide “bioinformatics for the next generation.” Jivan will offer content for targeted sequencing with mRNA capture arrays, mRNA specific PCR […]

SANTA CLARA, Calif., & COLUMBUS, Ohio–Agilent Technologies Inc. (NYSE:A) today announced that The Research Institute at Nationwide Children’s Hospital has achieved Certified Service Provider (CSP) status for Agilent microarrays. Certification is for array-based comparative genomic hybridization (aCGH) and gene expression assays on the Agilent platform. These microarrays are used to investigate the relationships between genes […]

SUNNYVALE, CA–(April 7, 2009) – Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces a new research collaboration with The Parkinson’s Institute of Sunnyvale, California to discover biomarkers for Parkinson’s disease. This unique study involves the prospective collection of samples from well-characterized Parkinson’s patients combined with Arrayit’s new H25K microarray technology. The first […]

Agilent Also Introduces Labeling Kit, Purification Module to Increase Throughput, Reduce Costs SANTA CLARA, Calif.–Agilent Technologies, Inc. (NYSE:A) today introduced the Human CNV Association 2x105K microarray for studying associations between genomic copy number variations (CNV) and disease. The array is based on a design by the Wellcome Trust Case Control Consortium (WTCCC), which is conducting […]

MADISON, Wis.–The most commonly diagnosed form of childhood leukemia, acute lymphoblastic leukemia (ALL), often responds well to biologically-targeted therapeutic treatments, but also carries a 25% risk for relapse. ALL is frequently associated with a chromosomal translocation that involves the specific translocation of gene loci from the short (p) arm of chromosome 12 to chromosome 21 […]

SEATTLE–Rosetta Biosoftware today announced that Stanford University has licensed the Syllego™ system for the management and analysis of genetic data produced by the GENEticS of Insulin Sensitivity (GENESIS) consortium. GENESIS researchers in the Quertermous lab at Stanford University will use the Syllego system to support genome-wide association studies (GWAS) targeted at the genetic mechanisms underlying […]